Parkman Healthcare Partners LLC Icad Inc Transaction History

Parkman Healthcare Partners LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$3.92 - $7.48 $404,943 - $772,698	-103,302 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$6.7 - $11.38 $145,376 - $246,923	-21,698 Reduced 17.36%	103,302 $744,000
Q3 2021 Nov 12, 2021	SELL	$10.11 - $17.56 $4.11 Million - $7.13 Million	-406,255 Reduced 76.47%	125,000 $1.34 Million
Q2 2021 Aug 13, 2021	SELL	$14.9 - $20.82 $1.74 Million - $2.43 Million	-116,876 Reduced 18.03%	531,255 $9.2 Million
Q1 2021 May 14, 2021	BUY	$12.57 - $21.22 $1.33 Million - $2.24 Million	105,529 Added 19.45%	648,131 $13.8 Million
Q4 2020 Feb 12, 2021	SELL	$8.73 - $14.56 $341,779 - $570,024	-39,150 Reduced 6.73%	542,602 $7.16 Million
Q3 2020 Nov 13, 2020	SELL	$8.56 - $11.6 $1.23 Million - $1.67 Million	-143,838 Reduced 19.82%	581,752 $5.13 Million
Q1 2020 May 15, 2020	BUY	$6.94 - $14.42 $866,833 - $1.8 Million	124,904 Added 20.79%	725,590 $5.33 Million
Q4 2019 Feb 13, 2020	BUY	$6.23 - $7.98 $3.74 Million - $4.79 Million	600,686 New	600,686 $4.67 Million

5.48M

3.6K

14.6K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $73.7M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.